Position in NVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$565,445
+$64,578 QoQ
Shares Held
3,608
+10.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#836
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KANAWHA CAPITAL MANAGEMENT LLC holds $95,466,643 across 8 Drug Manufacturers - General names. NVS ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
148,501 | $37,714,798 | |
| 2 | ABBV |
AbbVie Inc.
|
141,643 | $35,643,044 | |
| 3 | LLY |
ELI LILLY & Co
|
8,046 | $9,650,614 | |
| 4 | PFE |
Pfizer Inc
|
290,647 | $6,998,779 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
40,741 | $2,347,496 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,938 | $1,662,533 | |
| 7 | AMGN |
Amgen Inc
|
2,441 | $883,934 | |
| 8 | NVS |
Novartis AG
This page
|
3,608 | $565,445 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $565,445 | 3,608 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $500,867 | 3,279 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $454,143 | 3,294 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $432,681 | 3,374 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $422,808 | 3,494 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $389,511 | 3,494 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $325,015 | 3,340 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $384,166 | 3,340 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $362,496 | 3,405 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $329,365 | 3,405 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $337,239 | 3,340 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $340,212 | 3,340 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $337,039 | 3,340 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $307,280 | 3,340 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $303,004 | 3,340 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $248,248 | 3,266 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $280,893 | 3,323 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $288,346 | 3,286 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $292,499 | 3,344 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $279,687 | 3,420 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $302,004 | 3,310 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $286,614 | 3,353 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $316,623 | 3,353 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $291,576 | 3,353 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $290,318 | 3,324 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $274,063 | 3,324 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||